Rehmann Capital Advisory Group’s Evolent Health EVH Stock Holding History

Rehmann Capital Advisory Group’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-720	Closed	-$5.72K	–	1787
2019 Q2	$5.72K	Hold	720	–	–	﹤0.01%	1520
2019 Q1	$9.06K	Hold	720	–	–	﹤0.01%	1363
2018 Q4	$14.4K	Sell	720 -13,957	-95%	-$323K	﹤0.01%	947
2018 Q3	$417K	Buy	14,677 +13,979	+2,003%	+$333K	0.06%	241
2018 Q2	$14.7K	Sell	698 -24	-3%	-$454	﹤0.01%	1206
2018 Q1	$10K	Buy	+722	New	+$10.3K	﹤0.01%	1304

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Rehmann Capital Advisory Group's EVH Position: Q3 2019 in Review

Rehmann Capital Advisory Group sold out of Evolent Health (EVH) in Q3 2019, closing a stake of 720 shares — an estimated $5.72K sold.

Rehmann Capital Advisory Group first reported a position in EVH in Q1 2018 and held it in 6 quarters. The position peaked at $417K in Q3 2018. 174 funds tracked by Wall St. Rank hold EVH as of Q3 2019.

Rehmann Capital Advisory Group reported no remaining Evolent Health position as of Q3 2019 after selling out during the quarter.
Rehmann Capital Advisory Group sold 720 Evolent Health shares in Q3 2019, an estimated $5.72K.
Rehmann Capital Advisory Group first reported a position in Evolent Health in Q1 2018 and held it in 6 quarters.
Rehmann Capital Advisory Group's Evolent Health position peaked at $417K in Q3 2018.
174 funds tracked by Wall St. Rank held Evolent Health as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.